{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:10:00Z","timestamp":1795036200291,"version":"4.10.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274589"],"award-info":[{"award-number":["82274589"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973912"],"award-info":[{"award-number":["81973912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Innovation Project in China Academy of Chinese Medical Sciences","award":["CI2021A02602"],"award-info":[{"award-number":["CI2021A02602"]}]},{"name":"China Center for Evidence-based Medicine of Traditional Chinese Medicine Special Project for Director of Business Research Office","award":["2020YJSZX-2"],"award-info":[{"award-number":["2020YJSZX-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Retinitis pigmentosa (RP) is an inherited disease characterized by a progressive loss of rod photoreceptors of the eye, leading to irreversible blindness. To date, to our knowledge, no clinical prospective studies have been undertaken that could document the effect of interventions that could reverse or reduce the progression of this disease. The application of microcurrent stimulation (ES) of the eye in the treatment of chronic eye diseases such as glaucoma and age-related macular degeneration has been used over several decades and has been reported to have beneficial effects to reduce the progression of these blinding diseases and has been supported by animal studies and smaller clinical studies, but to date, no large randomized clinical trials on the use of microcurrent therapy have been published. More recent clinical reports have also shown beneficial effects of ES on slowing the progression of RP but also lacks data from robust prospective clinical outcome studies. To our knowledge, this is the first prospective randomized study to evaluate the safety and clinical effectiveness of transpalpebral electrical stimulation (TpES) on the progression of RP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Randomized prospective study using N-of-1 trial 3 single-blind, crossover comparisons. The intervention period of each comparison is divided into treatment period and control period which are randomized arranged. Twelve participants will be strictly recruited in N-of-1 trial by the researcher in accordance with the inclusion and exclusion criteria. The main outcome of interest examined after each cycle of the 8-week intervention period is the assessment of the visual field (VF). Other variables of interest are best corrected visual acuity (BCVA), retinal function using electroretinogram (ERG), and visual function using NEI VFQ-25 questionnaire. Objective assessments of retinal changes will be undertaken using optical coherence tomography (OCT) and fundus autofluorescence (FAF).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The trial will evaluate the efficacy and safety of microcurrent stimulation on RP and provide high-quality evidence for clinical application through N-of-1 trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry; ChiCTR2300067357; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=174635\">https:\/\/www.chictr.org.cn\/showproj.html?proj=174635<\/jats:ext-link>.\u00a0Registered on\u00a05 January 2023<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-024-07933-0","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T02:04:20Z","timestamp":1706321060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transpalpebral electrical stimulation for the treatment of retinitis pigmentosa: study protocol for a series of N-of-1 single-blind, randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Wei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torkel","family":"Snellingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-7852","authenticated-orcid":false,"given":"Lina","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"issue":"6","key":"7933_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/13816810.2019.1703014","volume":"40","author":"MA Albarry","year":"2019","unstructured":"Albarry MA, Hashmi JA, Alreheli AQ, Albalawi AM, Khan B, Ramzan K, et al. Novel homozygous loss-of-function mutations in RP1 and RP1L1 genes in retinitis pigmentosa patients. Ophthalmic Genet. 2019;40(6):507\u201313. https:\/\/doi.org\/10.1080\/13816810.2019.1703014. PMID: 31833436.","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"7933_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.18240\/ijo.2019.06.06.PMID:31236346","volume":"12","author":"YS Hu","year":"2019","unstructured":"Hu YS, Song H, Li Y, Xiao ZY, Li T. Whole-exome sequencing identifies novel mutations in genes responsible for retinitis pigmentosa in 2 nonconsanguineous Chinese families. Int J Ophthalmol. 2019;12(6):915\u201323. https:\/\/doi.org\/10.18240\/ijo.2019.06.06.PMID:31236346.","journal-title":"Int J Ophthalmol"},{"key":"7933_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres2018.03.005","volume":"66","author":"SK Verbakel","year":"2018","unstructured":"Verbakel SK, van Huet RAC, Boon CJFC, den Hollander AI, Collin RWJ, Klaver CCW, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157\u201386. https:\/\/doi.org\/10.1016\/j.preteyeres2018.03.005. PMID: 29597005.","journal-title":"Prog Retin Eye Res"},{"key":"7933_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.exer.2017.07.004","volume":"162","author":"J Zhang","year":"2017","unstructured":"Zhang J, Xu D, Ouyang H, Hu S, Li A, Luo H, et al. Neuroprotective effects methyl 3,4 dihydroxybenzoate in a mouse model of retinitis pigmentosa. Exp Eye Res. 2017;162:86\u201396. https:\/\/doi.org\/10.1016\/j.exer.2017.07.004. PMID: 28709891.","journal-title":"Exp Eye Res"},{"issue":"4","key":"7933_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/archopht.122.4.460","volume":"122","author":"AY Chow","year":"2004","unstructured":"Chow AY, Chow VY, Packo KH, Pollack JS, Peyman GA, Schuchard R. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol. 2004;122(4):460\u20139. https:\/\/doi.org\/10.1001\/archopht.122.4.460. PMID: 15078662.","journal-title":"Arch Ophthalmol"},{"key":"7933_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exer.2016.06.010","volume":"149","author":"AM Hanif","year":"2016","unstructured":"Hanif AM, Kim MK, Thomas JG, Ciavatta VT, Chrenek M, Hetling JR, et al. Whole-eye electrical stimulation therapy preserves visual function and structure in P23H\u20131 rats. Exp Eye Res. 2016;149:75\u201383. https:\/\/doi.org\/10.1016\/j.exer.2016.06.010. PMID: 27327393.","journal-title":"Exp Eye Res"},{"issue":"1","key":"7933_CR7","doi-asserted-by":"publisher","first-page":"e000096","DOI":"10.1136\/bmjophth-2017-000096","volume":"2","author":"SK Wagner","year":"2017","unstructured":"Wagner SK, Jolly JK, Pefkianaki M, Gekeler F, Webster AR, Downes SM, et al. Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: results from the TESOLAUK trial. BMJ Open Ophthalmol. 2017;2(1):e000096. https:\/\/doi.org\/10.1136\/bmjophth-2017-000096. PMID: 29354722.","journal-title":"BMJ Open Ophthalmol"},{"issue":"12","key":"7933_CR8","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1016\/j.clinph.2018.09.019","volume":"129","author":"PC Iyer","year":"2018","unstructured":"Iyer PC, Madhavan S. Non-invasive brain stimulation in the modulation of cerebral blood flow after stroke: a systematic review of transcranial doppler studies. Clin Neurophysiol. 2018;129(12):2544\u201351. https:\/\/doi.org\/10.1016\/j.clinph.2018.09.019. PMID: 30384025.","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"7933_CR9","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1111\/aos.13581","volume":"96","author":"AK Bittner","year":"2018","unstructured":"Bittner AK, Seger K, Salveson R, Kayser S, Morrison N, Vargas P, et al. Randomized controlled trial of electro-stimulation therapies to modulate retinal blood flow and visual function in retinitis pigmentosa. Acta Ophthalmol. 2018;96(3):e366\u201376. https:\/\/doi.org\/10.1111\/aos.13581. PMID: 29130647.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"7933_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1167\/iovs.16-19906","volume":"58","author":"A Schatz","year":"2017","unstructured":"Schatz A, Pach J, Gosheva M, Naycheva L, Willmann G, Wilhelm B, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled follow-up study over 1 year. Invest Ophthalmol Vis Sci. 2017;58(1):257\u201369. https:\/\/doi.org\/10.1167\/iovs.16-19906. PMID: 28114587.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7933_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00417-017-3858-8","volume":"256","author":"AK Bittner","year":"2018","unstructured":"Bittner AK, Seger K. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):299\u2013306. https:\/\/doi.org\/10.1007\/s00417-017-3858-8. PMID: 29222719.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7933_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2019.01.015","volume":"698","author":"K Kawamura","year":"2019","unstructured":"Kawamura K, Kano Y. Electrical stimulation induces neurite outgrowth in PC12m3 cells via the p38 mitogen-activated protein kinase pathway. Neurosci Lett. 2019;698:81\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2019.01.015. PMID: 30634009.","journal-title":"Neurosci Lett"},{"issue":"8","key":"7933_CR13","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.4103\/1673-5374.303015","volume":"16","author":"K Chang","year":"2021","unstructured":"Chang K, Enayati S, Cho KS, Utheim TP, Chen DF. Non-invasive electrical stimulation as a potential treatment for retinal degenerative diseases. Neural Regen Res. 2021;16(8):1558\u20139. https:\/\/doi.org\/10.4103\/1673-5374.303015. PMID: 33433481.","journal-title":"Neural Regen Res"},{"issue":"2","key":"7933_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.expneurol.2012.08.029","volume":"238","author":"WT Zhou","year":"2012","unstructured":"Zhou WT, Ni YQ, Jin ZB, Zhang M, Wu JH, Zhu Y, et al. Electrical stimulation ameliorates light-induced photoreceptor degeneration in vitro via suppressing the proinflammatory effect of microglia and enhancing the neurotrophic potential of M\u00fcller cells. Exp Neurol. 2012;238(2):192\u2013208. https:\/\/doi.org\/10.1016\/j.expneurol.2012.08.029. PMID: 22974557.","journal-title":"Exp Neurol"},{"issue":"7","key":"7933_CR15","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.18632\/aging.103038","volume":"12","author":"L Cong","year":"2020","unstructured":"Cong L, Gao Z, Zheng Y, Ye T, Wang Z, Wang P, et al. Electrical stimulation inhibits Val-boroPro-induced pyroptosis in THP-1 macrophages via sirtuin3 activation to promote autophagy and inhibit ROS generation. Aging (Albany NY). 2020;12(7):6415\u201335. https:\/\/doi.org\/10.18632\/aging.103038. PMID: 32289749.","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"7933_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3969\/j.issn.1005-0779.2010.06.011","volume":"26","author":"H Sun","year":"2010","unstructured":"Sun H, Fan XR. Clinical study on the treatment of retinitis pigmentosa with acupuncture and medicine. J Clin Acupunct Moxibustion. 2010;26(6):20\u20132. https:\/\/doi.org\/10.3969\/j.issn.1005-0779.2010.06.011.","journal-title":"J Clin Acupunct Moxibustion"},{"issue":"7","key":"7933_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.7507\/1672-2531.201901075","volume":"19","author":"XL Chen","year":"2019","unstructured":"Chen XL. Sample size estimation for single case randomized controlled trial (N-of-1 trial). Chin J Evid Based Med. 2019;19(7):871\u20134. https:\/\/doi.org\/10.7507\/1672-2531.201901075.","journal-title":"Chin J Evid Based Med"},{"issue":"4","key":"7933_CR18","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.1111\/aos.13940","volume":"97","author":"C Bevers","year":"2019","unstructured":"Bevers C, Blanckaert G, Van Keer K, Fils JF, Vandewalle E, Stalmans I. Semi-automated kinetic perimetry: comparison of the Octopus 900 and Humphrey visual field analyzer 3 versus Goldmann perimetry. Acta Ophthalmol. 2019;97(4):e499\u2013505. https:\/\/doi.org\/10.1111\/aos.13940. PMID: 30345638.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"7933_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/ceo.13458","volume":"47","author":"M Iftikhar","year":"2019","unstructured":"Iftikhar M, Usmani B, Sanyal A, Kherani S, Sodhi S, Bagheri S, et al. Progression of retinitis pigmentosa on multimodal imaging: the PREP-1 study. Clin Exp Ophthalmol. 2019;47(5):605\u201313. https:\/\/doi.org\/10.1111\/ceo.13458. PMID: 30552737.","journal-title":"Clin Exp Ophthalmol"},{"key":"7933_CR20","first-page":"78","volume":"27","author":"T Verdina","year":"2021","unstructured":"Verdina T, Greenstein VC, Tsang SH, Murro V, Mucciolo DP, Passerini I, Mastropasqua R, Cavallini GM, Virgili G, Giansanti F, Sodi A. Clinical and genetic findings in Italian patients with sector retinitis pigmentosa. Mol Vis. 2021;27:78\u201394 PMID: 33688152.","journal-title":"Mol Vis"},{"issue":"8","key":"7933_CR21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/IAE.0b013e318242b838","volume":"32","author":"E Garcia-Martin","year":"2012","unstructured":"Garcia-Martin E, Pinilla I, Sancho E, Almarcegui C, Dolz I, Rodriguez-Mena D, et al. Optical coherence tomography in retinitis pigmentosa: reproducibility and capacity to detect macular and retinal nerve fiber layer thickness alterations. Retina. 2012;32(8):1581\u201391. https:\/\/doi.org\/10.1097\/IAE.0b013e318242b838. PMID: 22922847.","journal-title":"Retina"},{"key":"7933_CR22","doi-asserted-by":"publisher","first-page":"3846867","DOI":"10.1155\/2021\/3846867","volume":"2021","author":"G Miura","year":"2021","unstructured":"Miura G, Baba T, Tatsumi T, Yokouchi H, Yamamoto S. Effects of cataract surgery on vision-related quality of life in patients with retinitis pigmentosa and the predictive factors of quality of life improvement. Biomed Res Int. 2021;2021:3846867. https:\/\/doi.org\/10.1155\/2021\/3846867. PMID: 34552984.","journal-title":"Biomed Res Int"},{"issue":"5","key":"7933_CR23","doi-asserted-by":"publisher","first-page":"e057193","DOI":"10.1136\/bmjopen-2021-057193","volume":"12","author":"G Miura","year":"2022","unstructured":"Miura G, Ozawa Y, Shiko Y, Kawasaki Y, Iwase T, Fujiwara T, et al. Evaluating the efficacy and safety of transdermal electrical stimulation on the visual functions of patients with retinitis pigmentosa: a clinical trial protocol for a prospective, multicentre, randomised, double-masked and sham-controlled design (ePICO trial). BMJ Open. 2022;12(5):e057193. https:\/\/doi.org\/10.1136\/bmjopen-2021-057193. PMID: 35523495.","journal-title":"BMJ Open"},{"key":"7933_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/1874364100802010132","volume":"2","author":"K Shinoda","year":"2008","unstructured":"Shinoda K, Imamura Y, Matsuda S, Seki M, Uchida A, Grossman T, et al. Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration. Open Ophthalmol J. 2008;2:132\u20136. https:\/\/doi.org\/10.2174\/1874364100802010132. PMID: 19526044.","journal-title":"Open Ophthalmol J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-07933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-07933-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-07933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T18:04:24Z","timestamp":1706378664000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-07933-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7933"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-07933-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial will be in accordance by the Declaration of Helsinki and Ethical Guidelines for Clinical Research. The updated version of trial protocol (version 2.0, 1 December 2022) has been reviewed and approved on 23 December 2022 (YKEC-KT-2022\u2013043-P002) by the ethics committee of Eye Hospital, China Academy of Chinese Medical Sciences, and registered in the Chinese Clinical Trial Registry. Informed consent will be obtained from all the study participants and their legal guardian. The study is in progress. All documents communicating with the ethics committee will be reposited by the principal investigator. Modifications of the protocol will be reviewed by the ethics committee and implemented after approval. Later results will be registered in ChiCTR and made available to participants in accordance with the terms described in the documents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}